WATERTOWN, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced presentations at the American Society of Gene and Cell Therapy (ASGCT) 22nd Annual Meeting being held April 29-May 2, 2019 in Washington, D.C. Poster presentations will detail the significant advantages of cell squeezing over electroporation as a technique for engineering T cells, as well as the strong anti-tumor potential of SQZ-APCs.
Details on the presentations are as follows:
Presentation Title: Tumor-specific T cell engineering for enhanced effector function via microfluidic delivery of bioactive molecules
Presenter: Luke Cassereau, Ph.D.
Poster Session Title: Cell Therapies II
Poster Session Date and Time: Tuesday, Apr. 30, 2019 5:00 p.m. – 6:00 p.m. EDT
Location: Washington Hilton, Columbia Hall, Board No. 191
Presentation Title: Engineering Antigen Presenting Cell (APC) Cancer Therapies using the SQZ Platform
Presenter: Katarina Blagovic, Ph.D.
Poster Session Title: Cancer Immunotherapy, Cancer Vaccines II
Poster Session Date and Time: Wednesday, May 1, 2019 5:00 p.m. – 6:00 p.m. EDT
Location: Washington Hilton, Columbia Hall, Board No. 118
Additional details can be found on the conference website.
About SQZ Biotech
SQZ Biotech is a privately held company creating innovative treatments by transforming cells into sophisticated therapeutics. Using its proprietary platform, SQZ has the unique ability to precision engineer any cell type and deliver multiple materials, resulting in powerful, multifunctional cell therapies for a range of diseases with an initial focus on cancer and autoimmune disease. The first applications for the company leverage SQZ’s ability to generate target-specific immune responses, both in activation for the treatment of solid tumors, and immune suppression for the treatment of auto-immune diseases. For more information please visit www.sqzbiotech.com.
SQZ Contact:
Rebecca Cohen
Senior Manager, Corporate Relations
rebecca.cohen@sqzbiotech.com
617-758-8672 ext. 728
Media Contact
Cait Williamson, PhD
LifeSci Public Relations
cait@lifescipublicrelations.com
646-751-4366